In addition, functional T cells are required for the development of arthritis in these models,"8 and it is possible to show genetic restriction at the T cell level of antigen recognition, both in the intact animals and at a clonal level in vitro.- '4 Thus in rats there is a strain dependent correlation between Col 11 antibodies and development of arthritis,'~" and the arthritis can be transferred by in jection of immunoglobulin concentrate or purified Col 11 antibodies from immunised arthritic rats to healthy recipients. 417 Collagen induced arthritis in rats and mice has been shown to be mediated by complement-fixing Col II antibodies. 4 '" These findings suggest that such antibodies maiy play a primary part in the initiation and pathogenesis of some forms of arthritis in experimental animals.
Antibodies as well as T cell reactivity to Col II have been described in patients with RA. ')2-6 These findings imply that autoimmunity to Col II may have a role in disease initiation and pathogenesis of RA, as can be shown in animal models.
A number of groups have identified native or denatured, or both. Col II antibodies in patients with RA and have speculated on their potential pathogenetic role. The role of autoimmunity to Col II remains to be clarified in human disease, however, as several factors have emerged which cause its primary role in disease pathogenesis to be questioned. For example, it has become apparent that these antibodies are not confined to RA but can be detected in other rheumatic diseases,2224 and in the case of antibodies to denatured Col II, in a substantial proportion of normal individuals.-"
The present study was designed to assess the incidence of antibodies to both native and denatured human Col 11 in RA, other forms of arthritis, other autoimmune connective tissue diseases, and certain chronic inflammatory conditions. Such a study. including a wider range of diseases than those usually chosen, should help clarify any role of autoimmunity to Col II in the pathogenesis of RA.
Patients and methods S U BJ EFCTS
The patient group comprised 76 There was no correlation between antibody activity and the presence or titre of RF. Of the four patients who showed high antibody activity to native Col II, two were negative for RF and the other two had RF titres of 1/40 and 1/160. In addition, some sera with high RF titre did not have native Col II (A) antibody activity. Similar findings were noted in patients with denatured Col II antibody. There wias also no correlation between ESR or disease duration with antibody activity, and patients who were antibody positive did not differ from others with respect to drug treatment (data not showni). These findings are consistent with those reported by others. 2-except for the incidence of the atntibodies, which was slightly lower in the present study. 21 23 > This discrepancy can be expliained by the fact that the criterion used to determine al positive sample in the present study was more stringent (3SD) than that used by most others (2SD). Selection of the lower cut off point produced a higher incidence of positives, but this resulted in some positive sera in the normal control group. The upper limit was therefore retained at the 3SD level.
Interestingly, low antibody activities to both native and denatured Col II were detected in patients with AS, and the mean antibody levels were significantly higher (p<0-01) in this group than in the normal control group. These values were only just above the cut off values, and the biological significance of this reactivity remains to be determined.
Antibody activity was not detectable in patients with RS, PSA, and gout. Only a small number of serum samples were studied, however, and it may be premature to conclude that such antibodies aire always absent from this group of patients. No antibodies were found in any of the 28 patients with OA.
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